What is AngioDynamics's R&D?

AngioDynamics (ANGO) reported R&D of $7.08M in Q4 2025.

How has AngioDynamics's R&D changed year-over-year?

AngioDynamics's R&D increased by 2.5% year-over-year, from $6.91M to $7.08M.

What is the long-term trend for AngioDynamics's R&D?

Over 4 years (2021 to 2025), AngioDynamics's R&D has grown at a -7.9% compound annual growth rate (CAGR), from $36.39M to $26.22M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

AngioDynamics ANGO R&D

R&D at other companies

AbbottABT

$767M+7.1%

Becton, Dickinson and CompanyBDX

$249M+7.3%

TFX

TeleflexTFX

$44.39M+75.5%

StrykerSYK

$413M+2.0%

Merit Medical SystemsMMSI

$22.61M+0.6%

ICU MedicalICUI

$21.28M-8.6%

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's R&D?: AngioDynamics (ANGO) reported R&D of $7.08M in Q4 2025.
How has AngioDynamics's R&D changed year-over-year?: AngioDynamics's R&D increased by 2.5% year-over-year, from $6.91M to $7.08M.
What is the long-term trend for AngioDynamics's R&D?: Over 4 years (2021 to 2025), AngioDynamics's R&D has grown at a -7.9% compound annual growth rate (CAGR), from $36.39M to $26.22M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.